Scott Gottlieb

Scott Gottlieb (born June 11, 1972) is an American physician and investor who previously served as the 23rd commissioner of the Food and Drug Administration (FDA) from May 2017 until April 2019. He is presently a senior fellow at the conservative think tank the American Enterprise Institute (AEI), a partner at the venture capital firm New Enterprise Associates (NEA), and a member of the board of directors of drug maker Pfizer, Inc and gene sequencing company Illumina, Inc. Gottlieb is a contributor to cable financial news network CNBC and the CBS News program ''Face the Nation.'' An elected member of the National Academy of Medicine, he is the author of ''The New York Times'' best selling book ''Uncontrolled Spread'' on the COVID-19 pandemic and the national security vulnerabilities that it revealed. His forthcoming book, ''The Miracle Century: Making Sense of the Cell Therapy Revolution'', traces the scientific achievements that propelled progress in cell therapies.

Before becoming FDA Commissioner, he was a Clinical Assistant Professor at New York University Grossman School of Medicine, the FDA's Deputy Commissioner for Medical and Scientific Affairs, a venture partner with New Enterprise Associates (NEA) from 2007 to 2017, a member of the policy board of the Leukemia & Lymphoma Society, a senior official at the Centers for Medicare & Medicaid Services and a member of the Federal Health Information Technology Policy Committee, which advises the United States Department of Health and Human Services on healthcare information technology. He was previously a resident fellow at AEI from 2007 to 2017, prior to joining the FDA as Commissioner in May 2017. Provided by Wikipedia